A type 2 diabetes diagnosis does not make you uninsurable. It makes your application more complex. The outcome depends almost entirely on how well your diabetes is controlled — measured primarily by your A1C level — and whether you have developed any of the cardiovascular or renal complications that underwriters watch most closely.
In 2026, the underwriting picture for diabetic applicants is actually improving for a specific subset: those taking GLP-1 medications (Ozempic, Mounjaro, Wegovy, Zepbound) who show consistent adherence and improving health metrics. A landmark Munich Re study of 41 million insured lives published in early 2026 found that consistent GLP-1 users showed up to a 20% reduction in major cardiovascular events and lower all-cause mortality. Underwriters are beginning to incorporate this data — not uniformly, but selectively at carriers who have updated their manuals.
How Underwriters Evaluate a Diabetic Applicant
When your application lists a type 2 diabetes diagnosis, the underwriter evaluates several factors in sequence:
| Factor | Favourable Signal | Unfavourable Signal |
|---|---|---|
| A1C level | Under 7.0% (well controlled) | Above 7.5–8.0% (poorly controlled) |
| Time since diagnosis | 5+ years stable | Recent diagnosis with unstable trend |
| Medication type | Metformin alone or + GLP-1 with adherence | Insulin dependence (higher risk signal) |
| Blood pressure | Controlled, under 130/80 | Uncontrolled hypertension |
| Kidney function | Normal eGFR and creatinine | Nephropathy (reduced kidney function) |
| BMI | Improving or stable | Severely elevated, worsening |
| Diabetic complications | None | Retinopathy, neuropathy, nephropathy, cardiovascular events |
The most important number in your application is your A1C. Most major carriers use these benchmarks as rough thresholds:
- A1C under 7.0%: Standard or near-standard rates available at most carriers
- A1C 7.0–7.5%: Rated policy with a higher premium; coverage available
- A1C above 7.5–8.0%: Many traditional carriers decline; simplified issue and guaranteed issue options remain
How GLP-1 Medications Are Changing Underwriting in 2026
Before 2025, a GLP-1 prescription on an application was largely read as a proxy for the underlying condition — diabetes or obesity — and rated accordingly. The medication itself was not a positive or negative signal.
That is beginning to change. The Munich Re 41-million-life study is prompting more sophisticated underwriters to distinguish between GLP-1 users who show compliance and improving metrics versus those who do not. Insurance data now shows that patients with at least 80% adherence to their GLP-1 therapy show significantly better long-term outcomes than non-adherent patients or non-GLP-1 users with similar baseline A1C levels.
What this means practically: if you are a GLP-1 user applying for life insurance in 2026, demonstrating your compliance history is as important as your current A1C. Consistent refill records, lab values trending in the right direction, and a treating physician who can document your response to treatment give a forward-looking underwriter reason to rate you more favourably.
Not all carriers have updated their manuals to reflect this data. Carrier variation is significant — this is the primary reason working with an impaired risk specialist (a broker who specialises in applicants with health conditions) matters. They know which carriers are ahead of the curve on GLP-1 data and can route your application accordingly.
Your Coverage Options as a Diabetic Applicant
Traditional Term or Whole Life Insurance (A1C under ~7.5%)
If your diabetes is well controlled, you are eligible for traditional underwritten policies. These offer the best rates and the highest coverage amounts — up to $5 million or more under accelerated underwriting programs. Apply with your most recent labs. If your A1C has improved over the past year, that trend matters more than a single snapshot.
Simplified Issue Life Insurance (A1C 7.5%–9.0%)
Simplified issue policies skip the full medical exam and use a shorter set of health questions. You will pay more than traditional rates, but coverage amounts up to $500,000 are available. Not every simplified issue carrier takes diabetic applicants — shop multiple options.
Guaranteed Issue Life Insurance (Any A1C, Any Complications)
Guaranteed issue policies — including Mutual of Omaha’s final expense products — accept all applicants regardless of health history. No medical exam and no health questions. Coverage amounts are limited (typically $2,000–$25,000 depending on age) and premiums are higher, but this is the safety net that ensures every diabetic applicant has access to some level of coverage. There is typically a 2-year graded benefit period during which the full death benefit is not paid for natural death causes.
Employer Group Life Insurance
Many employers offer group life insurance as a benefit — typically 1–3x annual salary — with no individual medical underwriting. If you are employed and your employer offers this benefit, it is available to you regardless of your diabetes status. The coverage is not portable when you leave — see our guide on what happens to life insurance when you leave a job.
How to Approach Your Application
Several practical steps improve your outcome as a diabetic applicant:
- Get current labs before applying. If your last A1C was six months ago and it was improving, get a fresh test. An improving trend in recent labs is more convincing than older stable data.
- Work with an impaired risk specialist. Submit informal inquiries to multiple carriers before filing any formal application. Every formal denial is recorded on your MIB file and visible to subsequent carriers. An impaired risk broker submits informally and routes your application to the carrier most likely to approve it.
- Document your GLP-1 compliance if applicable. Ask your prescribing physician for a letter confirming your ongoing treatment, adherence, and response. This directly addresses the question underwriters are now trained to ask about GLP-1 users.
- If denied, request a re-rating in 12–24 months. If your condition improves significantly and your A1C drops into the favourable range, most carriers allow a re-rating request that can reduce your premium. A rated policy today does not lock you into that rate forever.
